← Open Payments lookup

KENDYL COLEMAN: Open Payments

NPI 1447838701 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,213 in 92 payments from 30 companies in 2025. Trend: 2023 $5,385 · 2024 $2,419 · 2025 $2,213

Food & beverage: $2,213
CompanyPaymentsAmount
ABBVIE INC.15$340
Biogen, Inc.7$290
EMD Serono, Inc.8$213
Novartis Pharmaceuticals Corporation17$196
E.R. Squibb & Sons, L.L.C.1$122
ARGENX US, INC.3$77
Axsome Therapeutics, Inc.3$71
UCB, Inc.2$71
PFIZER INC.3$70
Teva Pharmaceuticals USA, Inc.3$63

Products named: QULIPTA, TYSABRI, KESIMPTA, ZEPOSIA, UBRELVY, LEQEMBI, REXULTI, VYVGART HYTRULO.

Industry payments across GA — which companies pay providers there.